Literature DB >> 1404317

Azole drug resistance in Candida species.

D W Warnock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1404317     DOI: 10.1099/00222615-37-4-225

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  12 in total

1.  Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients.

Authors:  A Schoofs; F C Odds; R Colebunders; M Ieven; H Goossens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

2.  Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.

Authors:  A L Colombo; F Barchiesi; D A McGough; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

3.  Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.

Authors:  G P Moran; D J Sullivan; M C Henman; C E McCreary; B J Harrington; D B Shanley; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

4.  Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients.

Authors:  D Sullivan; D Bennett; M Henman; P Harwood; S Flint; F Mulcahy; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

Review 5.  The role of Candida albicans secreted aspartic proteinase in the development of candidoses.

Authors:  L Hoegl; M Ollert; H C Korting
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

6.  Susceptibilities of Candida spp. to antifungal agents visualized by two-dimensional scatterplots of relative growth.

Authors:  F C Odds; G Dams; G Just; P Lewi
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

7.  Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.

Authors:  F C Odds; L Vranckx; F Woestenborghs
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

8.  Improved medium for fluconazole susceptibility testing of Candida albicans.

Authors:  J L Rodriguez-Tudela; J V Martinez-Suarez
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

9.  Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole.

Authors:  D Garcia-Hermoso; F Dromer; L Improvisi; F Provost; B Dupont
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

10.  Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.

Authors:  G P Moran; D Sanglard; S M Donnelly; D B Shanley; D J Sullivan; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.